Dashboard
Manage Tickers

AXGNAxogen, Inc.

Nasdaq axogeninc.com


$ 5.85 $ 0.04 (0.69 %)    

Wednesday, 08-May-2024 15:59:07 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 5.87
$ 5.78
$ 0.00 x 0
$ 5.88 x 100
$ 5.78 - $ 6.06
$ 3.45 - $ 10.83
264,676
na
253.78M
$ 1.28
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 03-05-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-14-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 10-30-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-24-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 10-29-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 04-30-2018 03-31-2018 10-Q
26 02-28-2018 12-31-2017 10-K
27 11-01-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 05-04-2017 03-31-2017 10-Q
30 03-01-2017 12-31-2016 10-K
31 11-02-2016 09-30-2016 10-Q
32 08-03-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-05-2015 03-31-2015 10-Q
38 03-05-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-04-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

axogen-reiterates-fy24-outlook-expects-revenues-to-grow-between-177m-181m-vs-17951m-estimate--which-represents-a-growth-rate-of-approximately-11-14
Axogen Reiterates FY24 Outlook: Expects Re...
05/02/2024 11:53:07

axogen-q1-2024-adj-eps-006-beats-007-estimate-sales-41378m-miss-41964m-estimate
Axogen Q1 2024 Adj EPS $(0.06) Beats $(0.0...
05/02/2024 11:18:26

Axogen (NASDAQ:AXGN) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14....

axogen-announces-first-surgical-implants-of-avive-soft-tissue-matrix
Axogen Announces First Surgical Implants o...
04/29/2024 20:51:27

why-sophia-genetics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why SOPHiA GENETICS Shares Are Trading Low...
03/05/2024 18:11:47

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expect...

axogen-expects-2024-revenue-of-177m-181m-up-11-14-versus-consensus-of-17922m-with-gross-margin-of-76-79
Axogen Expects 2024 Revenue Of $177M-$181M...
03/05/2024 12:12:01

axogen-q4-eps-006-beats-010-estimate-sales-4290m-beat-4165m-estimate
Axogen Q4 EPS $(0.06) Beats $(0.10) Estima...
03/05/2024 12:09:58

Axogen (NASDAQ:AXGN) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.10) by 40 ...

earnings-scheduled-for-march-5-2024
Earnings Scheduled For March 5, 2024
03/05/2024 10:00:02

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2...

axogen-earnings-preview
Axogen Earnings Preview
03/04/2024 15:01:29

cantor-fitzgerald-reiterates-overweight-on-axogen-maintains-12-price-target
Cantor Fitzgerald Reiterates Overweight on...
01/19/2024 14:24:57

Cantor Fitzgerald analyst Ross Osborn reiterates Axogen (NASDAQ:AXGN) with a Overweight and maintains $12 price target.

axogen-reports-topline-results-from-repose-clinical-trial-of-axoguard-nerve-cap-post-marketing-study-met-its-primary-endpoint-for-reduction-in-pain-as-measured-by-visual-analog-scale
Axogen Reports Topline Results From REPOSE...
01/18/2024 22:01:48

crude-oil-rises-over-2-constellation-brands-posts-downbeat-sales
Crude Oil Rises Over 2%; Constellation Bra...
01/05/2024 19:30:55

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 50 points on Friday. The Dow trad...

why-applied-therapeutics-shares-are-trading-lower-by-over-35-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Applied Therapeutics Shares Are Tradin...
01/05/2024 18:13:57

Shares of Applied Therapeutics, Inc.

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
01/05/2024 17:31:05

greenbrier-posts-upbeat-earnings-joins-kura-sushi-usa-axogen-and-other-big-stocks-moving-higher-on-friday
Greenbrier Posts Upbeat Earnings, Joins Ku...
01/05/2024 15:18:34

U.S. stocks traded higher, with the Dow Jones index gaining more than 100 points on Friday. Shares of The Greenbrier Companies...

axogen-reports-preliminary-q4-revenue-of-427m-up-18-yy-consensus-4068m-now-expects-2023-revenue-to-be-at-high-end-of-the-154m-159m-guidance-range-consensus-15675m
Axogen Reports Preliminary Q4 Revenue Of $...
01/04/2024 21:49:11

axogen-president-and-ceo-karen-zaderej-plans-to-retire-from-company-by-january-2025
Axogen President And CEO Karen Zaderej Pla...
01/04/2024 21:41:52

The Company's Board of Directors will retain an executive recruitment firm to manage a search for her successor. When a new...

canaccord-genuity-reiterates-buy-on-axogen-maintains-11-price-target
Canaccord Genuity Reiterates Buy on Axogen...
12/07/2023 15:44:58

Canaccord Genuity analyst Caitlin Cronin reiterates Axogen (NASDAQ:AXGN) with a Buy and maintains $11 price target.

axogen-q3-2023-eps-010-misses-006-estimate-revenue-413m-beats-40456m-estimate
Axogen Q3 2023 EPS $(0.10) Misses $(0.06) ...
11/07/2023 12:03:50

earnings-scheduled-for-november-7-2023
Earnings Scheduled For November 7, 2023
11/07/2023 11:34:30

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

leerink-partners-initiates-coverage-on-axogen-with-outperform-rating-announces-price-target-of-9
Leerink Partners Initiates Coverage On Axo...
10/16/2023 15:37:51

Leerink Partners analyst Mike Kratky initiates coverage on Axogen (NASDAQ:AXGN) with a Outperform rating and announces Price...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION